Keyphrases
Pulmonary Hypertension
100%
Immunoreactivity
100%
Endothelin-1 (ET-1)
100%
Nitric Oxide Synthase Type III
100%
Rheumatic Heart Disease
80%
Disease Case
40%
Pulmonary Endothelial Dysfunction
20%
Lung
10%
Etiology
10%
AIMS™
10%
Hypertension Patients
10%
Cardiopulmonary Function
10%
Pulmonary Artery
10%
Immunohistochemical Staining
10%
Life-threatening
10%
Endothelium
10%
Autopsy
10%
Immunostaining
10%
Pulmonary Vasculature
10%
Multi-step Process
10%
Characteristic Changes
10%
Disease Etiology
10%
Systemic Factors
10%
Local Factors
10%
Autopsy Cases
10%
Bronchiolar Epithelium
10%
Lung Vasculature
10%
Elastica Van Gieson
10%
Medicine and Dentistry
Pulmonary Hypertension
100%
Immunoreactivity
100%
Endothelin 1
100%
Endothelial Nitric Oxide Synthase
100%
Rheumatic Heart Disease
80%
Lung
20%
Endothelial Dysfunction
20%
Vascularity
10%
Disease
10%
Pulmonary Artery
10%
Immunohistochemistry
10%
Pulmonary Vasculature
10%
Immunology and Microbiology
Immunoreactivity
100%
Nitric Oxide Synthase
100%
Endothelin
100%
Rheumatic Heart Disease
88%
Vascularization
22%
Immunostaining
11%
Pulmonary Artery
11%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelial Nitric Oxide Synthase
100%
Endothelin 1
100%
Pulmonary Hypertension
100%
Rheumatic Heart Disease
80%
Endothelial Dysfunction
20%
Biochemistry, Genetics and Molecular Biology
Immunoreactivity
100%
Endothelin 1
100%
Nitric Oxide Synthase
100%
Vascularization
22%
Immunostaining
11%